Neuphoria Therapeutics Inc. (NEUP) Return on equity
Neuphoria Therapeutics Inc. (NEUP) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-2.1%FY2025
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -2.1% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice